Iran: Stop the Slaughter of Innocents

 

Iran is now such a strategic threat that it made confrontation unavoidable. By the time of the current conflict, Iran was widely understood to possess the technical capability to produce multiple nuclear weapons on relatively short notice. Even short of full nuclear deployment, it could assemble radiological “dirty bombs,” which—while less destructive—would still have severe economic and psychological impacts if used.

At the same time, Iran made substantial advances in intermediate-range ballistic missile technology, enabling it to project power across the Middle East and beyond. This capability, paired with a potential nuclear or radiological payload, represents a major shift in regional deterrence dynamics.

Equally important is Iran’s network of proxy forces, including Hamas and Hezbollah. These groups already demonstrated their ability to launch large-scale missile attacks and maintain persistent threats against Israel and neighboring states. Given time to rearm and reorganize, they would again become destabilizing forces capable of triggering broader regional conflict.

Iran also holds a powerful economic lever: the Strait of Hormuz. With fortified positions and asymmetric naval capabilities, Iran has the means to disrupt global energy supplies. Any future attempt to halt its nuclear or missile programs could be met with actions capable of severely damaging the world economy.

Taken together, these elements demonstrate that delaying confrontation increases the risks rather than reducing them. As Iran approaches a threshold where its military and strategic capabilities can no longer be effectively countered, the ability of Israel and other states to defend themselves is eliminated.

America and Israel acting before these capabilities were fully realized was the only way to prevent a more dangerous and uncontrollable situation later. So far Iran, Syria, and Lebanon have killed hundreds of thousands of their own citizens. The United States and Israel are stopping this slaughter of innocents.

 

 

Longevity Differences Between the United States and Europe: The Role of Lifestyle Versus Medical Care

Recent data indicate that life expectancy in the United States is approximately 78–79 years, compared to about 81–82 years in Europe, depending on how Europe is defined. It is important to note that the commonly cited European average of ~81.5 years largely reflects Western Europe (e.g., France, Germany, Italy, Spain, the U.K., and Scandinavia). When Eastern Europe is included, the overall European average drops significantly—often into the mid-to-high 70s, closer to or even below the U.S. figure. Thus, comparisons between the United States and “Europe” often implicitly compare the U.S. to its most developed Western European peers.

The U.S. longevity gap relative to Western Europe—typically two to four years—is often attributed to differences in healthcare systems. However, when longevity is adjusted for major lifestyle and behavioral risk factors—such as violence, drug overdoses, obesity, smoking, and accidents—the disparity narrows substantially. This suggests that the primary drivers of the gap lie outside the healthcare system itself.

A key factor is mortality from external causes. The United States has significantly higher rates of homicide, accidental death, and drug overdose than Western Europe. These deaths disproportionately affect younger individuals, which has a large effect on overall life expectancy. When such causes are statistically removed, U.S. life expectancy rises markedly and approaches European levels.

Obesity is another major contributor. The United States has substantially higher obesity and severe obesity rates than most European countries. This increases the prevalence of cardiovascular disease, diabetes, and related conditions, particularly in middle age. Smoking patterns also differ historically and continue to influence mortality, though the gap has narrowed in recent decades.

When comparisons are restricted to populations without major behavioral risk factors—non-smokers, non-obese individuals, and those not affected by violence or substance abuse—U.S. life expectancy becomes broadly comparable to that of Western Europe.

In conclusion, once adjusted for lifestyle and behavioral factors, U.S. life expectancy appears to converge toward approximately 82–83 years, similar to Western European levels. If Eastern Europe is included in the comparison, the adjusted figures would be even more closely aligned, as Eastern European life expectancy is generally lower. These findings suggest that the observed longevity gap is driven primarily by lifestyle and social factors rather than differences in the quality of medical services.